The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.
- First select the CSR Section, then a Table/Figure from that section.
- Use the Submit button to view the table or figure. You will have options to download a printer-friendly version or the data table (CSV) as well.
To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 85 KB) and Technical Notes (PDF, 282 KB) pages.
Download and Print: Download Printer-friendly PDF Download data
Table 28.8
5-Year Relative Survival (Percent)
By Selected Primary Cancer Site and Year of Diagnosis
All Races, Males and Females
| Site | 1975-1977 | 1978-1980 | 1981-1983 | 1984-1986 | 1987-1989 | 1990-1992 | 1993-1995 | 1996-1998 | 1999-2002 | 2003-2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| All Sites, All Races | 57.9 | 62.4 | 67.0 | 68.0 | 71.6 | 75.8 | 77.4 | 79.1 | 80.7 | 83.1c |
| All Sites, Whites | 57.8 | 63.0 | 67.7 | 69.8 | 72.4 | 76.8 | 78.2 | 80.5 | 81.8 | 84.5c |
| All Sites, Blacks | 57.3 | 57.7 | 62.2 | 56.7 | 65.3 | 71.1 | 73.0 | 75.2 | 72.8 | 77.5c |
| Bone & Joint | 49.9d | 47.8 | 56.8d | 57.3d | 66.8d | 67.4 | 74.1 | 70.3 | 71.6 | 78.6c |
| Brain & ONS | 56.9 | 57.7 | 56.6 | 61.7 | 64.2 | 64.6 | 70.6 | 75.1 | 73.6 | 75.1c |
| Hodgkin lymphoma | 80.7 | 86.8 | 88.1 | 89.9 | 87.1 | 96.8 | 94.6 | 96.1 | 94.8 | 98.1c |
| Leukemia | 49.7 | 58.0 | 62.9 | 63.6 | 71.1 | 75.5 | 75.9 | 80.2 | 83.3 | 86.7c |
| Acute lymphocytic | 57.2 | 65.7 | 71.3 | 72.2 | 77.8 | 83.1 | 83.8 | 86.9 | 88.9 | 91.7c |
| Acute myeloid | 18.8 | 25.8 | 26.7d | 30.5d | 37.1d | 42.1 | 40.6d | 48.6 | 58.1 | 64.8c |
| Neuroblastomaa | 52.5 | 56.6 | 54.5 | 52.3 | 62.9 | 76.5 | 66.8 | 65.9 | 71.5 | 76.0c |
| Non-Hodgkin lymphoma | 43.2 | 52.7 | 66.9 | 69.5 | 70.7 | 76.9 | 80.7 | 83.2 | 88.3 | 85.1c |
| Soft tissue | 61.3 | 74.0 | 69.2 | 72.9 | 66.4 | 79.8 | 76.7 | 70.5 | 78.4 | 79.6c |
| Wilms' tumorb | 73.1 | 79.0 | 86.7 | 90.7 | 92.1 | 91.9 | 91.7 | 91.6 | 93.6 | 90.1c |
| Site | 1975-1977 | 1978-1980 | 1981-1983 | 1984-1986 | 1987-1989 | 1990-1992 | 1993-1995 | 1996-1998 | 1999-2002 | 2003-2009 |
|---|---|---|---|---|---|---|---|---|---|---|
| All Sites, All Races | 61.5 | 65.1 | 68.3 | 70.4 | 73.5 | 76.3 | 77.7 | 79.7 | 80.3 | 83.6c |
| All Sites, Whites | 61.3 | 65.8 | 69.2 | 72.3 | 75.0 | 77.6 | 78.5 | 81.0 | 81.4 | 84.9c |
| All Sites, Blacks | 59.5 | 60.0 | 62.5 | 58.4 | 64.4 | 68.7 | 74.0 | 73.6 | 73.8 | 76.9c |
| Bone & Joint | 50.4 | 48.1 | 51.2 | 56.0 | 63.9 | 68.8 | 68.9 | 67.0 | 68.3 | 73.9c |
| Brain & ONS | 58.9 | 58.1 | 58.3 | 63.8 | 65.9 | 66.5 | 71.4 | 75.9 | 74.2 | 75.1c |
| Hodgkin lymphoma | 86.1 | 88.3 | 85.5 | 90.6 | 88.6 | 94.2 | 93.9 | 95.2 | 95.5 | 97.4c |
| Leukemia | 44.9 | 53.2 | 58.0 | 60.3 | 67.6 | 71.3 | 71.8 | 76.5 | 77.9 | 84.6c |
| Acute lymphocytic | 53.8 | 61.9 | 67.1 | 69.9 | 75.0 | 79.8 | 81.4 | 84.3 | 84.7 | 90.0c |
| Acute myeloid | 18.7 | 26.2 | 26.4 | 31.4 | 37.6 | 41.9 | 38.6 | 46.2 | 52.8 | 63.9c |
| Neuroblastomaa | 53.0 | 56.7 | 53.4 | 52.5 | 61.5 | 76.2 | 66.8 | 66.1 | 71.1 | 76.4c |
| Non-Hodgkin lymphoma | 44.6 | 53.4 | 63.8 | 67.4 | 70.4 | 72.7 | 77.9 | 81.0 | 84.1 | 84.5c |
| Soft tissue | 64.8 | 68.7 | 68.4 | 72.6 | 68.0 | 69.7 | 73.7 | 72.2 | 73.9 | 76.1c |
| Wilms' tumorb | 72.6 | 78.3 | 86.8 | 91.0 | 92.1 | 91.3 | 91.7 | 91.7 | 93.6 | 89.8c |
Footnotes:
Source: SEER 9 areas (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, and Atlanta). Based on follow-up of patients into 2010.
Note: Neuroblastoma and Wilms' tumor are not mutually exclusive from the other tumors presented in table.
a Neuroblastoma is defined as histologies 9490-9509.
b Wilms' tumor is defined as histologies 8959-8960.
c The difference between 1975-1977 and 2003-2009 is statistically significant (p<.05).
d The standard error is between 5 and 10 percentage points.
e The standard error is greater than 10 percentage points.
- Statistic could not be calculated due to fewer than 25 cases during the time period.
Page Navigation: << Previous Next >>
The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.